Pharmascience Inc. v Janssen Inc.
The Supreme Court of Canada released its decision in Pharmascience Inc. v Janssen Inc., 2026 SCC 26 on July 17, 2026, dismissing Pharmascience’s appeal and upholding the validity of our client Janssen’s Invega Sustenna dosing regimen patent.
